University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms.
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
Chris Norton, Managing Director, InterSystems UK & Ireland, argues that a paper-light, data-driven, and energy-efficient approach plays a key role in delivering sustainability while aligning with the NHS Long Term Plan to take a digital approach.
Gary Davies, from Sandvik Materials Technology, explains how medical wires are helping patients monitor blood glucose levels without the need for daily testing.
A team at the Karolinska Institutet found that some patients who recovered by accessing depression treatment showed an increase in their average level of serotonin transporter.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.
In this study, nearly 900 people described an abnormal menstrual cycle after exposure to tear gas - which is legally considered to be "safe" as a crowd control measure.
A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.
Pfizer could make their COVID vaccine available to 12-year-olds in Europe from June, after clinical trials in March showed 100% efficiency for those aged 12 to 15.
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
The city of Manaus was hit so overwhelmingly by the Brazilian COVID mutation, it was believed that 75% of the population had COVID - what new truths are scientists learning about this powerful variant?
New data from the UK's vaccination programme suggests that one in four people get Pfizer and AstraZeneca vaccine side effects - with most peaking in the first 24 hours, then gone in two days.
